Pyrimidine nucleoside phosphorylase (PYNP) catalyzes the reversible phosphorolysis of pyrimidines in the nucleotide-synthesis salvage pathway. In order to study the structure-thermostability relationship of this enzyme, PYNP from the extreme thermophile Thermus thermophilus HB8 (TTHA1771) has been cloned, overexpressed and purified. The TTHA1771 protein was crystallized at 291 K using the oil-microbatch method with PEG 4000 as a precipitant. A native data set was collected to 1.8 Å resolution using synchrotron radiation. The crystal belongs to the monoclinic space group P2 1 , with unit-cell parameters a = 58.83, b = 76.23, c = 103.86 Å , = 91.3 . # 2007 International Union of Crystallography All rights reserved crystallization communications 310 Shimizu & Kunishima TTHA1771 Acta Cryst. (2007). F63, 308-310 Figure 2
Introduction
Pyrimidine nucleoside phosphorylase (PYNP; EC 2.4.2.2) is an enzyme that catalyzes the reversible phosphorolysis of pyrimidine nucleosides, yielding pyrimidine and ribose-1-phosphate or deoxyribose-1-phosphate. PYNP can accept most pyrimidine nucleosides as substrates, except for 4-amino-substituted species such as deoxycytidine. PYNP plays an important role in the catalysis of glycosidic bond cleavage in pyrimidine nucleotides by the phosphorolytic mechanism, providing the reuse of free bases in the nucleotidesynthesis salvage pathway. Higher order organisms including mammals and some bacteria such as Escherichia coli have two distinct PYNPs: thymidine phosphorylase (TP; EC 2.4.2.4) and uridine phosphorylase (UP; EC 2.4.2.3) (Gallo et al., 1967; Krenitsky et al., 1965; Paege & Schlenk, 1952) . However, in some lower order organisms such as Bacillus stearothermophilus (Saunders et al., 1969) and Haemophilus influenzae (Scocca, 1971) , only one PYNP is found and it does not discriminate between thymidine and uridine. Control of thymidine levels in vivo is thought to be critical for cell proliferation and hence inhibitors of TP have received considerable attention as potential cytotoxic antitumour agents (Schwartz & Milstone, 1988; Kirkwood et al., 1980) . The structure of TP from E. coli was initially determined at 2.8 Å resolution (Walter et al., 1990) . The tetragonal crystals showed an S-shaped homodimer in which the subunits were related by a crystallographic twofold axis. The monomeric protomer was composed of two domains: an -helical domain which was composed of six helices and an /-domain which included a six-stranded mixed -sheet and a four-stranded antiparallel -sheet. Similar S-shaped dimeric structures were observed in the homologous enzymes TP from Homo sapiens (Norman et al., 2004) and PYNP from B. stearothermophilus . For E. coli TP, two other crystal forms were observed: a monoclinic form and an orthorhombic form . Comparison of the E. coli TP structures in the three different crystal forms revealed that domain movement occurs upon ligand binding. However, further studies using liganded enzymes are likely to contribute additional mechanistic insights. In addition, the structure-thermostability relationship of this enzyme remains to be elucidated, since most studies to date have focused on enzymes from mesophilic and mesothermophilic organisms. Here, we present the expression, purification and crystallization of a PYNP orthologue, the TTHA1771 protein from the extreme thermophile Thermus thermophilus HB8, which has an optimum growth temperature of 348 K. TTHA1771 protein shares 50% (220/433) sequence identity with B. stearothermophilus PYNP (PDB code 1brw), 44% (185/420) with H. sapiens TP (PDB code 1uou) and 41% (173/420) with E. coli TP (PDB code 1tpt). The structural determination of the TTHA1771 protein and structural comparison with homologous enzymes may provide insight into the reaction and thermostabilization mechanism of this family of enzymes.
Experimental

Protein expression and purification
The gene encoding TTHA1771 protein was cloned from the T. thermophilus HB8 genome (Yokoyama et al., 2000) . The TTHA1771 protein is composed of 423 amino acids (residues 1-423) with a molecular weight of 45.4 kDa. Protein expression and purification were performed by the Structurome Research Group at the RIKEN SPring-8 Center as follows using a routine procedure. E. coli BL21 (DE3) cells were transformed with the recombinant expression plasmid pET-11a carrying the TTHA1771 gene and grown at 310 K in Luria-Bertani medium containing 50 mg ml À1 ampicillin for 20 h. The cells were harvested by centrifugation at 20 000g for 4 min and suspended in 20 mM Tris-HCl pH 8.0 (buffer A) containing 500 mM NaCl, 5 mM 2-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride. The cells obtained were disrupted by sonication and heated at 343 K for 13 min. After the heat treatment, cell debris and denatured proteins were removed by centrifugation (21 600g, 30 min) and the supernatant was used as the crude extract for purification. The crude extract was desalted using a HiPrep 26/10 desalting column (Amersham Biosciences) and applied onto a Super Q Toyopearl 650M column (Tosoh) equilibrated with buffer A. Proteins were eluted with a linear gradient of 0-0.3 M NaCl. After buffer replacement with buffer A, the fraction containing TTHA1771 was subjected to a Resource Q column (Amersham Biosciences) equilibrated with buffer A and eluted with a linear gradient of 0-0.3 M NaCl in buffer A. After buffer replacement with 10 mM phosphate-NaOH pH 7.0 (buffer B), the fraction containing TTHA1771 was applied onto a Bio-Scale CHT-20-I column (Bio-Rad) equilibrated with buffer B and eluted with a linear gradient of 10-100 mM NaCl in buffer B. The fraction containing TTHA1771 was concentrated by ultrafiltration (Vivaspin, 10 kDa cutoff, Vivascience) and loaded onto a HiLoad 16/ 60 Superdex 200 prep-grade column (Amersham Biosciences) equilibrated with buffer A containing 0.2 M NaCl. The homogeneity and identity of the purified sample were assessed by SDS-PAGE and N-terminal sequence analysis. Finally, the purified TTHA1771 was concentrated to 21.7 mg ml À1 by ultrafiltration and kept at 203 K.
Dynamic light scattering
The oligomeric state of the purified TTHA1771 was examined by a dynamic light-scattering (DLS) experiment using a DynaPro MS/X instrument (Protein Solutions). The concentration of the protein solution was 20.0 mg ml À1 in 20 mM Tris-HCl buffer pH 7.6 with 200 mM NaCl. Several measurements were taken at 291 K and analyzed using the DYNAMICS software v.3.30 (Protein Solutions). A particle-size distribution with a polydispersity of 18.7% was observed and the molecular weight was estimated to be 86.3 kDa, which is consistent with a dimeric state of this protein in solution.
Crystallization and X-ray diffraction study
An initial screening of crystallization conditions was carried out using the TERA automatic crystallization system (Sugahara & Miyano, 2002) , which is based on the oil-microbatch method (Chayen et al., 1990) , using Nunc HLA plates (Nalge Nunc International). After the initial screening, the crystallization conditions for TTHA1771 protein were optimized. The optimized precipitant solution consisted of 27.5%(w/v) PEG 4000 as precipitant, 0.1 M calcium chloride as additive and 0.1 M HEPES-NaOH pH 7.5 as buffer. A 0.5 ml aliquot of the optimized precipitant solution was mixed with 0.5 ml protein solution (21.7 mg ml À1 protein, 0.2 M NaCl, 20 mM Tris-HCl pH 8.0) in a well of the HLA plate. Subsequently, the 1 ml crystallization drop was covered with 15 ml of a 7:3(v/v) paraffin oil:silicon oil mixture, allowing slow evaporation of water in the drop, and stored at 291 K. Crystals with suitable dimensions for X-ray diffraction study were reproducibly obtained using the TERA system. The crystals were flash-cooled under a nitrogen-gas stream at 100 K using an oil-based cryoprotectant comprising 90% Paratone-N and 10% glycerol by weight (Kwong & Liu, 1999) . X-ray diffraction data were collected using a Rigaku Jupiter 210 CCD detector at BL26B1 of SPring-8, Japan (Ueno et al., 2006) . Diffraction images were integrated and scaled using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) .
Results
We have established the expression, purification and crystallization of the TTHA1771 protein. After one week at 291 K, monoclinic crystals grew with typical dimensions of 0.13 Â 0.13 Â 0.07 mm (Fig. 1) . The crystals diffracted X-rays to 1.8 Å resolution at 100 K using Optical micrograph of TTHA1771 crystals obtained by the oil-microbatch method. The scale bar represents 0.2 mm. (Matthews, 1968 ), corresponding to a solvent content of 51.7%, which is consistent with the result of the DLS experiment, which showed a dimeric state of this protein in solution (see x2). To examine the local symmetry in the asymmetric unit, self-rotation functions were calculated using MOLREP (Collaborative Computational Project, Number 4, 1994; Vagin & Teplyakov, 1997; Fig. 2) .
The search was carried out for angles of 180, 120, 90 and 60 to check for the presence of twofold, threefold, fourfold and sixfold axes, respectively. A local peak with a signal-to-noise ratio of 4.5 was found at = 180 , demonstrating the existence of twofold noncrystallographic symmetry at = 84.4, ' = 84.9 . We have obtained a clear molecular-replacement solution using the coordinates of the B. stearothermophilus PYNP (PDB code 1brw), which shows the highest sequence similarity to TTHA1771 in the PDB. The molecular-replacement result confirmed that the asymmetric unit contains a dimer with local pseudo-twofold symmetry. The pseudo-twofold axis of the dimer could be calculated by the superposition of one subunit onto the other using LSQKAB (Kabsch, 1976) as having spherical polar angles ! = 84.6, ' = 84.4, = 175.7 , which was consistent with the result of the self-rotation function. A detailed discussion of the crystal structure will be published elsewhere.
